Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin

NCT04204837 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of the Skin

Interventions

DRUG: Nivolumab
DRUG: Nivolumab plus Relatlimab

Sponsor

Salzburger Landeskliniken

Collaborators

[object Object]